Embla Medical Hf S/Adr (OSSUY) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Embla Medical Hf.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.993 -- 00:00:06.261 At this time, I would like to welcome everyone to this emblematical Q4 and annual 00:00:06.261 -- 00:00:09.065 report for 2025 conference 00:00:09.065 -- 00:00:14.172 call. Today's call is being recorded. If you have any objections, please 00:00:14.172 -- 00:00:19.340 disconnect at this time. Throughout the presentation, all participants will 00:00:19.340 -- 00:00:24.387 be in a listen-only mode. Afterwards, there will be a question and answer session. 00:00:24.387 -- 00:00:30.423 To ask a question during the Q&A, please press 5-star on your telephone keypad. 00:00:30.423 -- 00:00:32.926 I'll now turn the call over to your speakers. 00:00:32.926 -- 00:00:35.426 You may now begin. 00:00:36.029 -- 00:00:38.111 Thank you very much, operator. 00:00:38.111 -- 00:00:42.676 Good morning, and welcome to the Ampla Medical conference call, where we will review 00:00:42.676 -- 00:00:45.879 the fourth quarter and full year results for 2025. 00:00:45.879 -- 00:00:47.481 I'm 00:00:47.481 -- 00:00:50.564 Sved Solvason, President and CEO of Ampla Medical. 00:00:50.564 -- 00:00:55.549 Today, also joining me here is our Chief Financial Officer, Artna Svensdottir, and Ampla 00:00:55.549 -- 00:00:59.684 Medical's Head of Investor Relations, Klaus Sintas. 00:00:59.684 -- 00:01:05.092 The presentation should take approximately 20 minutes, after which there will be an opportunity 00:01:05.092 -- 00:01:11.638 to ask questions during a Q&A session. If you can please go to the next slide. 00:01:12.963 -- 00:01:18.331 2025 was a year of meaningful progress for Ample Medical, with several milestones 00:01:18.331 -- 00:01:22.758 as we continue to take steps on our journey to build a company that is focused on delivering 00:01:22.758 -- 00:01:27.765 products an...